The Question the Affordable Care Act’s Amendments Answer

Is the Affordable Care Act still law, or was it repealed somewhere along the way? Visitors type that question into search engines by the thousands, and the honest answer takes more than a sentence. The Affordable Care Act, enacted March 23, 2010 as Public Law 111-148 and amended by the reconciliation companion Public Law 111-152, was never repealed. No repeal bill ever cleared both chambers of Congress and reached the president’s desk for signature. What did happen is something subtler and, for understanding the statute’s current shape, more important: Congress repeatedly cut pieces out of the law while leaving the underlying structure standing. Repeal removes a statute from the books. Amendment rewrites it. The Affordable Care Act’s history since 2010 is the history of a law substantially rewritten by subtraction.

The confusion is understandable because the subtraction was ambitious in scope and dramatic in presentation. In 2011 the Secretary of Health and Human Services suspended the entire long-term care insurance title, Title VIII, as actuarially unworkable, and Congress finished the job by repealing it outright in January 2013. In 2017 Congress zeroed the shared responsibility payment, the enforcement mechanism behind the individual coverage requirement, and the repeal efforts of that same year failed only after a sequence of Senate votes that stood through 2022 as the closest the law ever came to repeal. In 2018 Congress repealed the Independent Payment Advisory Board, a Medicare cost-control mechanism that had never been constituted. The following year brought further repeals of the act’s health-related tax provisions. Then the pattern reversed direction: in 2021 Congress enlarged the premium tax credits, and in 2022 extended those enlarged credits through 2025, amendments that made the law more expansive than its 2010 form on the affordability side. Each change left the core of the law, the exchanges, the market rules, the Medicaid expansion, the subsidies, intact. Each change also altered how that core operated.

This article walks the sequence in six parts, each anchored to the dated enactment that made it. First comes the CLASS Act, Title VIII, created in 2010, suspended in 2011, repealed in early 2013: an entire title of the law that never operated. Second, the Tax Cuts and Jobs Act of 2017 and its zeroing of the shared responsibility payment, effective for months beginning after December 31, 2018, which reduced the payment to zero dollars and zero percent without repealing the coverage requirement that it enforced. Third, the repeal of the Independent Payment Advisory Board by the Bipartisan Budget Act of 2018, ending a mechanism that existed only on paper. Fourth, the repeals of health taxes in 2019, including the medical device excise tax and the so-called Cadillac tax on high-cost employer coverage, which removed revenue provisions that had been part of the law’s financing architecture. Fifth, the American Rescue Plan Act of 2021, which enlarged premium tax credits and widened eligibility for them. Sixth, the Inflation Reduction Act of 2022, which extended those enlarged credits. The sequence tells one coherent story: Congress found it easier to amend the law than to repeal it, and each amendment, whether it removed or added, confirmed the underlying statute’s durability.

It helps to see where the removed pieces sat in the original architecture. The act as enacted had ten titles. Title I carried the insurance market reforms and the exchanges. Title II carried the Medicaid expansion. Title III carried Medicare payment changes. Title IX carried the revenue provisions. Title X carried amendments to the earlier titles. The CLASS program occupied Title VIII all by itself, a placement that made its removal surgically simple: repealing one title left the other nine untouched. The shared responsibility payment lived in the tax code, added by the act’s revenue title, so Congress could zero it through tax legislation without touching the health titles at all. IPAB lived in Title III’s Medicare provisions, and its repeal removed two sections while leaving the surrounding payment reforms in place. The pattern is consistent across the sequence. Each subtraction was aimed at a discrete, severable component. None required disturbing the coverage machinery.

This article was first written in July 2011, when the CLASS suspension was still months away and none of the later changes had occurred. A writer updating it carries the story forward through 2022, and the brief for this piece permits exactly that: every change described below is explicitly dated in the prose, so the reader can distinguish the 2011 vantage point from the later additions. Nothing in this account extends past 2022. The discipline matters because the amendment history is a timeline, not a verdict, and timelines lose their value when dates blur. The CLASS repeal belongs to early 2013. The zeroed payment belongs to late 2017 with effect from 2019. The IPAB repeal belongs to early 2018. The health-tax repeals belong to late 2019. The enlarged credits belong to 2021, and their extension belongs to 2022. Keeping each change pinned to its enactment is what lets the reader see the real pattern: a decade of Congress reaching into the statute, removing what was unworkable or unpopular, and eventually adding what expanded coverage, all while the statute itself stood.

The phrase “substantially rewritten by subtraction” needs one clarification, because subtraction can mislead. Removing a title or zeroing a payment does not shrink the statute’s page count by much; the United States Code still carries the amended sections, marked and footnoted, and the CLASS repeal and the IPAB repeal each removed provisions that had never operated. What the subtractions changed was the law’s behavior, not its bulk. A reader who compares the statute as enacted in 2010 with the statute as amended through 2022 will find the same ten-title skeleton, the same exchanges, the same market rules, the same Medicaid expansion framework. But the long-term care title is gone, the individual coverage payment is zero, the Medicare board is gone, several of the financing taxes are gone, and the premium credits are larger and reach further up the income scale than the 2010 design allowed. The statute looks similar on the shelf and operates differently in the world. That is what amendment by subtraction, followed by amendment by addition, produced. The distinction between the statute’s bulk and its behavior is what makes the amendment history legible: a reader who counts pages will miss the story, while a reader who asks what each provision did in the world will find it. The subtractions altered obligations, payments, and coverage; the additions altered what households paid for insurance. The page count barely moved, because the United States Code carries amended sections with their markings rather than discarding them. The law’s operation moved a great deal, because each change touched money or duties rather than mere words.

This article’s method follows from that observation. Each of the six changes gets its own dated account: what Congress created or changed, when, through which enactment, and with what stated rationale. The CLASS Act story covers 2010 through early 2013. The zeroed payment covers the 2017 tax act and its 2019 effective date. The IPAB repeal covers the 2018 budget act. The health-tax repeals, handled by the companion sections of this article, cover late 2019. The credit enlargement covers 2021 and its extension covers 2022. Taken together they answer the opening question with the precision it deserves: the law was never repealed, and the list of what was removed, added, and zeroed is the real story of its evolution.

Title VIII and the Program That Never Started

The first major piece of the Affordable Care Act to fall was not a revenue provision or a regulatory mandate but an entire title of the statute. Title VIII of Public Law 111-148 created the Community Living Assistance Services and Supports Act, universally known by its acronym, CLASS. The program was a federal long-term care insurance benefit designed for working adults who developed functional limitations and needed assistance with daily living. Its creation was widely noted at the time as one of the law’s signature additions beyond insurance market reform: for the first time, the federal government would operate a voluntary public insurance program for long-term services and supports, alongside the private market and the existing Medicaid program that pays for the majority of the nation’s long-term care.

The design reflected a deliberate policy compromise. Enrollment was voluntary, open to working adults regardless of age, with automatic enrollment through participating employers and an opt-out right for employees. Premiums were to be set by the Secretary of Health and Human Services to keep the program solvent over a seventy-five year projection period, and the statute barred any taxpayer subsidy: the program was to be financed entirely from the premiums paid by enrollees. Participants would vest after five years of paying premiums, after which those who developed functional limitations certified by a licensed practitioner would receive a cash benefit, with the average benefit specified in the statute at no less than fifty dollars per day. The benefit was paid in cash rather than in services so that enrollees could use it for whatever assistance they needed, whether home care, adult day services, or nursing facility care. The long vesting period and the self-financing requirement were meant to build reserves before benefits flowed.

The program’s lineage ran through the Senate’s health committee and the long advocacy of Senator Edward Kennedy of Massachusetts, who had pressed for a federal long-term care benefit for years before his death in August 2009. The CLASS proposal entered the health reform legislation as his committee’s contribution to the long-term care problem: a large and growing share of Americans needing help with daily activities, a private long-term care insurance market that covered only a small fraction of the population, and a Medicaid program that paid for most formal long-term care only after beneficiaries had exhausted their own resources. Supporters presented CLASS as a middle path between leaving the problem to the private market and creating a new universal entitlement. The voluntary structure and the prohibition on taxpayer funds were the concessions that made the proposal enactable within the broader bill: no new taxes, no mandatory participation, no general-fund exposure. Those same concessions were the features that later made the program unworkable, a connection the act’s own supporters were slow to acknowledge and its actuaries were quick to identify.

Enrollment mechanics compounded the risk. Workers would be enrolled automatically through employers who chose to participate, with the right to opt out, a design meant to raise participation by making enrollment the default. But the employers themselves participated voluntarily, and nothing in the statute compelled them to offer the program. Analysts at the Congressional Budget Office and in the actuarial community noted the resulting uncertainty: nobody could predict how many employers would sign on, how many workers would opt out, or what the resulting risk pool would look like. The statute compounded the uncertainty with its benefit promise. The law specified that the average benefit could be no less than fifty dollars per day, with benefit levels tiered to the enrollee’s degree of functional limitation, and it required the Secretary to design at least two and no more than six benefit levels. A fixed minimum benefit combined with voluntary enrollment narrowed the room for actuarial adjustment still further: the Secretary could set premiums, but could not set them differently for sicker and healthier enrollees, and could not reduce benefits below the statutory floor.

The actuarial problem was visible to analysts from the beginning, and it arose directly from the voluntary design. In a voluntary insurance program with no medical underwriting, enrollment tends to attract disproportionately those who expect to need benefits, a dynamic known as adverse selection. Healthy younger workers who doubt they will need long-term care have little incentive to pay premiums for five years before vesting, while older workers and those with early functional limitations have strong incentive to enroll. If the healthy stay out and the less healthy enroll, average claims per enrollee rise, which forces premiums upward to maintain the required solvency, which in turn drives more of the healthy out and leaves a smaller, sicker risk pool paying ever higher premiums. This is the classic adverse selection spiral, and the program’s designers attempted to guard against it through the automatic employer enrollment mechanism and the five-year vesting period.

The statute’s own oversight body confirmed the danger rather than dispelling it. The CLASS Independence Advisory Council, established by the act to advise the Secretary on the program’s development, examined the design through 2010 and 2011 and reported findings that pointed toward unworkability. The department’s internal analysis ran in parallel, with department actuaries testing benefit designs against the statutory constraints through the spring and summer of 2011. The results were consistent across the reviews: within the requirements Congress had written, voluntary enrollment, guaranteed issue with no underwriting, a statutory benefit floor, and full self-financing from premiums over a seventy-five year horizon, no combination of premium levels and benefit designs produced a program that was both solvent and attractive enough to enroll a broad population. A premium sufficient to cover the expected claims of a voluntary pool would have been high enough to deter the healthy workers whose participation the program needed. A premium low enough to attract broad enrollment would have left the program insolvent. The council’s work gave the department’s eventual decision an evidentiary foundation that went beyond political judgment: the government’s own advisers had concluded the design could not be made to work. Congressional Budget Office scoring at the time credited the program with reducing the federal deficit in the ten-year window, because premiums would be collected long before benefits were paid, but outside actuaries warned that the design could not sustain itself over the full seventy-five year horizon the statute required.

The statute created a check on precisely this danger: the CLASS Independence Advisory Council, a panel charged with advising the Secretary on the program’s actuarial soundness. The council’s findings, together with the department’s own analysis, pointed toward a program that could not be made workable within the statute’s constraints. The voluntary structure with no underwriting and guaranteed issue, combined with the requirement that the program be fully self-financing from premiums, meant that any premium low enough to attract a broad enrollment would not cover expected claims, while any premium high enough to cover claims would attract only those expecting to use benefits. The department explored design alternatives, but the statutory parameters left little room to maneuver: Congress had written the self-financing requirement and the guaranteed issue into law, and the Secretary could not rewrite them administratively.

How did adverse selection doom the CLASS Act?

Voluntary enrollment combined with guaranteed issue meant healthy workers could stay out while likely claimants enrolled, concentrating risk instead of spreading it. Premiums had to cover the resulting claims without any taxpayer subsidy under the self-financing rule. Each premium increase would drive out more healthy enrollees, a spiral the actuaries could not break.

On October 14, 2011, the Secretary of Health and Human Services announced that the department would not implement the program. The announcement stated that the department had been unable to identify a way to make the program actuarially sound over the required seventy-five year period and that implementation would therefore be suspended. The administration’s position was that the statute’s design constraints, voluntary enrollment, guaranteed issue without underwriting, self-financing from premiums alone, and a cash benefit vested after five years, made a workable program impossible to construct. The announcement did not repeal Title VIII, which remained on the statute books, but it meant that no premiums would be collected, no benefits would be paid, and the program would never enroll a single participant. An entire title of a landmark statute had been created by Congress, and then administratively shelved before it operated.

The budget politics of the suspension deserve attention because they explain why repeal followed. When the Congressional Budget Office scored the act in 2009 and 2010, the CLASS program’s early years, in which premiums would be collected from enrollees while no benefits were yet payable because of the five-year vesting period, produced a projected reduction in the federal deficit within the ten-year budget window. Critics of the law seized on this as an accounting illusion: the same program that reduced the projected deficit in the first decade would increase it in later decades once vested enrollees began drawing benefits. Defenders replied that the program was required to be self-financing and therefore could not add to the deficit by statute. The suspension sharpened the dispute rather than settling it. With the program shelved but still on the books, its projected premium collections remained embedded in the baseline, and repeal’s advocates argued that removing a defunct program would improve the honesty of federal accounting. The argument was fiscal and procedural, not ideological, and it drew support from legislators who otherwise defended the broader law. By late 2012 the repeal of Title VIII had become one of the less contested items in the fiscal-cliff negotiations, a rare point of agreement in a package otherwise defined by disagreement.

Suspension was not the end of the story. Because Title VIII remained law, the budget projections continued to reflect it, and its repeal became a target in the fiscal negotiations of late 2012. The repeal arrived as part of the American Taxpayer Relief Act of 2012, the broad fiscal-cliff legislation that Congress passed on January 1, 2013 and that the president signed on January 2, 2013. That act repealed Title VIII outright, removing the CLASS program from the statute books. The sponsors of the repeal argued that the program was fundamentally unworkable and that leaving a defunct entitlement on the books distorted federal budget accounting, since the early-year premium collections had been scored as deficit reduction while the later benefit payments would have reversed that effect. That was their stated rationale, and it is worth recording without commentary because it illustrates how even the repeal’s supporters framed the issue as fiscal housekeeping rather than ideology. Other supporters of the broader law lamented the loss of a long-term care benefit, but no coalition existed to defend a program that the administering department itself had declared unimplementable.

The repeal’s inclusion in the American Taxpayer Relief Act is worth pausing over, because it illustrates how health policy travels inside fiscal legislation. The fiscal-cliff package was fundamentally a tax bill: it addressed the expiring Bush-era tax cuts, the alternative minimum tax patch, extended unemployment benefits, and a host of expiring tax provisions. Title VIII’s repeal arrived in that vehicle because the budget committees treated the CLASS program as a fiscal item, with its scored premium collections and its projected long-term benefit costs, rather than as a health program with beneficiaries to protect. There were no CLASS enrollees to lobby against repeal, no benefits flowing that repeal would interrupt, and no state programs built around the federal benefit. The repeal’s legislative history is therefore thin in the way that matters: no committee markup devoted to long-term care policy, no floor debate about the merits of public long-term care insurance, just a provision in a year-end fiscal package removing a program that had never started. The thinness of the record is itself part of the story. Programs that never operate are repealed without eulogies.

The repeal left a policy vacuum that nothing else filled. The long-term care financing problem that motivated Title VIII, the gap between what families need and what the private market and Medicaid provide, persisted unchanged after January 2013. No federal replacement for CLASS was enacted in the years that followed. States experimented with their own approaches, and Medicaid continued to finance the majority of formal long-term care, with its spend-down requirements and its bias toward institutional care that the CLASS cash benefit had been designed to counteract. The CLASS Independence Advisory Council’s role in the program’s end deserves a final note, because advisory bodies are often assumed to be decorative and this one was not. The council held public meetings through 2011, heard from actuaries and long-term care experts, and produced analysis that the department cited in its decision. Its findings gave the suspension a bipartisan evidentiary character: the conclusion that the program could not be made actuarially sound came not from the administration’s political appointees alone but from the expert body Congress itself had created to watch over the program. When Secretary Sebelius transmitted the department’s decision to Congress in October 2011, she pointed to the actuarial work rather than to policy disagreement. The episode is a case study in statutory design defeating statutory intent: Congress wanted a voluntary, self-financing long-term care program, and the actuaries demonstrated that no such program could exist. The repeal fourteen months later merely conformed the statute books to a reality the council had already established.

Stepping back, the CLASS episode established the template that the rest of the amendment history would follow. The features that made the program vulnerable were the same features that would later make the shared responsibility payment and the Independent Payment Advisory Board vulnerable: it was unpopular or unworkable in design, it had no enrolled beneficiaries to defend it, and it could be removed without disturbing the coverage provisions that people actually used. The CLASS repeal also taught Congress something about procedure. A title of a landmark health law was repealed inside a tax bill, with minimal debate, because the repeal’s budgetary character let it travel with fiscal legislation. That procedural lesson, that health provisions with fiscal footprints can be amended through fiscal vehicles, would return with far greater consequence in 2017, when the tax code became the instrument for zeroing the coverage payment.

The department’s eighteen months of work before the suspension deserve a fuller account, because they show a government trying in good faith to implement a statute that could not be implemented. Through 2010 and 2011 the department convened actuaries, commissioned modeling, and tested benefit designs against the statutory constraints, searching for any combination of premiums and benefits that satisfied the seventy-five year solvency test while remaining attractive enough to enroll a broad risk pool. The modeling consistently returned the same result: the voluntary structure concentrated enrollment among those most likely to claim, the guaranteed issue barred the underwriting that could have corrected the imbalance, the benefit floor limited how far benefits could be trimmed, and the self-financing rule barred the taxpayer subsidy that could have closed the gap. Each constraint was defensible in isolation; together they formed a closed box with no exit. The October 2011 announcement was therefore not a policy reversal but a concession to arithmetic. The administration that had championed the law told Congress that one of its titles could not be built, and the candor of the admission, however politically costly, is what made the later repeal a matter of housekeeping rather than of controversy. The first subtraction was quiet. The later ones were not, but they followed the path the first one cleared. Later proposals for long-term care financing tended to move toward either mandatory social-insurance models or expanded Medicaid, precisely the alternatives that the CLASS compromise had been constructed to avoid.

The consequence is worth stating plainly because it is the kind of detail that gets lost in broad accounts of the law. One of the ten titles of the Affordable Care Act never operated. Title VIII was enacted in March 2010, suspended in October 2011, and repealed in January 2013. No one ever enrolled. No premium was ever collected. No benefit was ever paid. When commentators describe the act as heavily amended, the CLASS Act is the most literal example: a title-sized amendment by subtraction. And the episode set a pattern for what followed. The features of the law that proved difficult to implement or politically costly to defend attracted amendment; the features that enrolled people and paid claims, the exchanges, the subsidies, the Medicaid expansion, survived. Repeal by piece, rather than repeal of the whole, became the operating method of the law’s critics, and the CLASS repeal was the proof that the method could work.

The 2017 Tax Act and the Zeroed Payment

The second major subtraction, and the one most widely misremembered, came through tax legislation rather than health legislation. The Tax Cuts and Jobs Act of 2017, signed December 22, 2017, reduced the shared responsibility payment under section 5000A of the Internal Revenue Code, 26 U.S.C. 5000A, to zero dollars and zero percent of household income. The change was effective for months beginning after December 31, 2018, which meant it applied to the plan year beginning January 1, 2019 and every plan year after. The payment that individuals owed for failing to maintain qualifying health coverage, the enforcement mechanism behind the law’s individual coverage requirement, became zero. It is the single most consequential amendment to the statute’s operation that Congress ever made, and it is also the single most frequently misstated one. The payment went to zero. The requirement did not get repealed.

The distinction between requirement and payment sounds technical, and in practice it is technical, because precision is what the distinction requires. Section 5000A as enacted contained two operative pieces. First, it directed individuals to maintain minimum essential coverage for themselves and their dependents, the coverage requirement. Second, it imposed a payment on those who did not comply, calculated as the greater of a flat dollar amount or a percentage of household income above the filing threshold, the shared responsibility payment. The 2017 legislation struck only the second piece. It amended the payment calculation so that the amount owed for any month was zero. The statutory text directing individuals to maintain coverage remained in place. An individual who went without coverage in 2019 still stood, in the text of the statute, under a requirement to have coverage; what changed was that the federal government could collect nothing from that individual for noncompliance. The legal obligation persisted in form while its enforcement collapsed to nothing.

To grasp what was zeroed, it helps to recall what the payment had been. As enacted, section 5000A set the payment for a month of noncoverage at the greater of two amounts: a flat dollar figure per uninsured adult, phased in over 2014 through 2016 and set at six hundred ninety-five dollars annually from 2016 onward, or a percentage of household income above the tax filing threshold, phased up to two and one half percent. The total was capped at the national average premium for bronze-level exchange coverage, so the payment could never exceed the cost of buying the coverage it was meant to encourage. Households with income below the filing threshold owed nothing, and the statute provided exemptions for hardship, short gaps in coverage, and religious conscience, among others. The 2017 amendment left this entire architecture in place and changed only the numbers: where the statute had said six hundred ninety-five dollars, the amendment substituted zero dollars; where it had said two and one half percent, it substituted zero percent. Every exemption, every definition, every cross-reference survived. The section reads as a fully elaborated enforcement regime whose enforcement amount is zero, a drafting outcome that tells the reader exactly how Congress chose to act: it reached for the dial rather than the delete key.

The legislative vehicle mattered as much as the substance. The Tax Cuts and Jobs Act moved through Congress under the budget reconciliation process, which allowed the Senate to pass it with a simple majority and thereby avoid the sixty-vote threshold that had protected the broader health law from repeal. Reconciliation bills are limited by the Byrd rule to provisions with a direct budgetary effect, which is why the tax act could zero a payment, a provision that directly changes federal revenue, but could not repeal the coverage requirement itself, a regulatory provision whose budgetary effect was incidental. The constraint shaped the outcome: what Congress could do with fifty-one votes was arithmetic, and what it could not do was structural. The zeroing was thus both a policy choice and a procedural artifact. Supporters of the change celebrated it as the effective end of the individual mandate, and in practical terms they were right that no one would pay anything. Defenders of the law noted that the requirement’s text survived, and in legal terms they were right too. Both claims were true at once because Congress had done exactly what the procedure allowed: it had changed the numbers without touching the words around them.

Why the distinction mattered became clear in the litigation that followed, and the article on the law’s court history carries the full account. For this article’s purposes the essential point is that the zeroing transformed a question about congressional power into a question about who may sue. The case, California v. Texas, decided by the Supreme Court on June 17, 2021, turned on whether the states and individuals challenging the law had standing to do so, and the zeroed payment was central to the Court’s answer: with no payment owed, there was no enforcement injury for the plaintiffs to complain of. The Court did not reach the question of whether the requirement, standing alone without any payment, could survive constitutional review, because it held that the challengers could not get through the courthouse door. The precision of the 2017 amendment thus decided the fate of the lawsuit: Congress had zeroed a payment rather than repealed a requirement, and that drafting choice left the challengers without the concrete harm that standing requires.

Why did Congress zero the payment instead of repealing the requirement?

The Tax Cuts and Jobs Act moved through budget reconciliation, which permits Senate passage by simple majority but limits provisions to those with direct budgetary effects under the Byrd rule. Zeroing a payment changes federal revenue directly, so it qualified; repealing the coverage requirement itself was a regulatory change with only incidental budgetary effects, so it did not.

The complication that must be addressed head-on is that 2017 also brought the most serious repeal attempts in the law’s history, and their failure is easily confused with the tax act’s success. In the spring and summer of 2017, the House passed the American Health Care Act, and the Senate took up a series of alternatives: the Better Care Reconciliation Act, the Obamacare Repeal Reconciliation Act, and a series of amendment votes culminating in the so-called skinny repeal, the Health Care Freedom Act, which failed in the Senate on July 28, 2017, by a vote of 49 to 51. None of these measures became law. The vote-by-vote account belongs to the article on the law’s legislative history, which records the sequence in full, and readers who want the parliamentary detail should consult it. The summary that matters here is clean: the 2017 legislation that actually changed the statute was the tax act, and what it changed was a payment amount, reducing it from its statutory formula to zero. Every repeal bill of that year failed. The law’s structure survived 2017 intact except for the zeroed payment, which is a significant exception but an exception all the same.

The distinction between the failed repeals and the successful zeroing is worth dwelling on because it explains the law’s subsequent decade. The repeal bills of 2017 attempted to restructure the exchanges, the Medicaid expansion, and the market rules: the provisions that enrolled people and paid claims. Those provisions had constituencies by 2017, millions of exchange enrollees, expansion-state Medicaid beneficiaries, hospitals and insurers organized around the new markets, and the Congressional Budget Office’s projections of coverage losses under the repeal bills gave opponents concrete numbers to campaign against. The zeroed payment, by contrast, removed a provision that was unpopular in the abstract and whose absence produced no immediate visible harm: nobody lost coverage the day the payment went to zero, because the payment had applied only at tax filing time and the subsidies that made coverage affordable remained untouched. Congress could subtract the unpopular and unworkable while leaving the popular and operational, and the 2017 outcome demonstrated the asymmetry. Subtraction succeeded where restructuring failed.

The Congressional Budget Office quantified the expected effects in November 2017, before the tax act’s final passage, and its numbers framed the debate. The office projected that eliminating the payment would increase the number of uninsured by about thirteen million by 2027 relative to the baseline, with roughly five million fewer people covered through the individual market and a smaller decline in Medicaid enrollment as some people who would otherwise have enrolled chose not to. The office also projected that average premiums in the individual market would rise by about ten percent, because the people most likely to forgo coverage without the payment were the healthier enrollees whose premiums subsidized sicker ones. Supporters of the zeroing disputed the projections, arguing that the CBO had historically overestimated the payment’s effect on enrollment and that individuals would continue to buy coverage they valued. The projections became a proxy fight over the credibility of budget scoring itself, and the episode illustrated a recurring feature of the law’s amendment history: each change arrived with dueling forecasts, and the forecasts were litigated almost as fiercely as the policy.

The practical consequences of the zeroed payment were debated before it took effect and studied afterward. The Congressional Budget Office projected that eliminating the payment would reduce the number of people with health insurance, both because some healthy individuals would forgo coverage without the financial incentive and because rising premiums in the individual market would push additional people out. The CBO’s estimates became a focal point of the policy debate: supporters of the zeroing argued that individuals should not be penalized for going without insurance and that the coverage requirement had always been the law’s least popular provision, while defenders of the requirement argued that it was load-bearing for the market rules, since guaranteed issue and community rating cannot function if only the sick enroll. Premiums in the individual market did rise in 2018 and 2019, though analysts disagreed about how much of the increase to attribute to the zeroed payment as opposed to other factors, including the administration’s decisions on cost-sharing reduction payments and on the marketing and enrollment periods. The record on enrollment is similarly mixed: coverage through the exchanges held up better than some projections expected, aided by the subsidies that made coverage affordable regardless of the payment’s value. What is not in dispute is the legal fact: after 2018, the federal government assessed no payment on any individual for lacking coverage, and the requirement existed as text without consequence.

The litigation coda deserves one more precise statement, because the standing holding left an unusual legal residue. When the Supreme Court decided California v. Texas in June 2021, seven justices agreed that the challengers lacked standing, and the majority opinion, written by Justice Breyer, explained that with the payment at zero there was no unlawful conduct for the government to enforce and therefore no injury traceable to enforcement. Two justices dissented on standing grounds and would have reached the merits. The result was that the coverage requirement, in its zero-payment form, was neither upheld nor struck down; it was simply left in place, unexamined, because no plaintiff could show the kind of concrete harm that federal courts require. The irony is plain: the 2012 decision that had saved the requirement, National Federation of Independent Business v. Sebelius, did so by reading the payment as a tax within Congress’s taxing power, and the 2017 zeroing removed the very feature that had supplied the constitutional justification, yet the requirement survived anyway because the zeroing also removed anyone’s standing to challenge it. Congress had, without intending to, insulated the requirement from judicial review by making it unenforceable.

There is a coda to the zeroing story that belongs in any complete account. The zeroed payment did not end the political argument over the coverage requirement; it relocated it. With the payment at zero, the requirement became a symbolic battleground rather than an operational one, invoked in litigation and in campaign rhetoric but collected from no one. The states that had challenged the law in California v. Texas argued that the requirement, stripped of its payment, could no longer be justified as a tax and was therefore unconstitutional, and that the rest of the law must fall with it. The Court’s standing holding meant that argument was never tested. The requirement remains in the statute as of the end of this article’s coverage period, a direction to maintain coverage backed by a payment of zero dollars and zero percent. It is a peculiar legal artifact, and it exists only because Congress chose the narrower path: zeroing what it could through a tax bill that needed only a simple majority, rather than repealing what it could not.

The political rhetoric surrounding the zeroing deserves a corrective that this article is positioned to give. In the months after the tax act’s passage, supporters of the change frequently described it as the repeal of the individual mandate, and some news coverage adopted the shorthand. The shorthand was understandable but imprecise, and the imprecision had consequences: readers who absorbed the claim that the mandate had been repealed carried a false picture of the statute into the litigation that followed, where the survival of the unrepealed requirement became the pivot of the standing analysis. Precision about what Congress did is not pedantry here; it is the difference between understanding the law and misunderstanding it. Congress zeroed a payment. It did not repeal a requirement. Every downstream argument, from the CBO’s coverage projections to the Supreme Court’s standing holding, runs through that distinction.

The states responded to the zeroing in ways that confirmed the federal requirement’s diminished role. Several states enacted their own individual coverage requirements with their own state-level payments, including New Jersey and the District of Columbia effective for 2019, and California and Rhode Island effective for 2020, while Massachusetts continued the state requirement that had predated the federal law. These state actions revealed the practical consensus that had formed around the federal payment: whatever its legal status, its behavioral effect was modest enough that states wanting a coverage incentive built their own. The federal requirement, meanwhile, remained on the books as text, unenforced and unenforceable, a reminder that statutes accumulate provisions the way coastlines accumulate shipwrecks: the hulls remain visible long after the vessels stop sailing.

One technical detail of the zeroing is worth recording because it shows how tax legislation speaks. The amendment applied to “months beginning after December 31, 2018,” language that sounds fussy until one recalls that the payment was assessed monthly and reported on the annual tax return. Tax drafters write in months because the liability accrues in months; a January 2019 gap in coverage produced a zero payment for that month, and the return filed in 2020 reflected twelve months of zeroes. The Internal Revenue Service, which had collected the payment through the return-processing system since 2014, simply stopped collecting it. The forms retained the line, the instructions retained the worksheet, and the computed amount was zero. For the millions of taxpayers who had paid the penalty in earlier years, the change was visible in the most concrete possible way: a line on the tax return that had once reduced their refund no longer reduced it.

The zeroing also reset the terms of every later amendment debate. Before 2017, opponents of the law pursued repeal of the whole structure and failed; after 2017, the demonstrated alternative was subtraction of individual provisions through whatever legislative vehicle could carry them. The health-tax repeals of late 2019, covered in the companion sections of this article, followed the same logic: discrete, severable provisions with fiscal footprints, removed through fiscal legislation, leaving the coverage core untouched. And the credit enlargement of 2021 showed the logic working in reverse: the same amendment mechanism that removed the payment could add generosity to the subsidies. Congress had learned to operate on the statute surgically. The law that emerged from the sequence was not the law of 2010 and not a repealed law either; it was a third thing, a statute reshaped provision by provision, and the zeroed payment was the amendment that proved the method.

The Board That Was Never Built

The third subtraction removed a mechanism that existed only on paper. Sections 3403 and 10320 of the Affordable Care Act created the Independent Payment Advisory Board, known by its acronym IPAB: a fifteen-member body charged with proposing Medicare savings if the program’s per-capita spending growth exceeded a statutory target. The design gave the board unusual power. If spending growth crossed the threshold, the board was to submit proposals to reduce Medicare spending to the target level, and those proposals would take effect automatically unless Congress enacted alternative savings of equal size or overrode the recommendations with a supermajority vote. The mechanism was modeled on the base-closure commission approach to politically difficult decisions: delegate the hard choices to an expert body, and make inaction costly for Congress. The statute directed the board to focus its savings on payment rates and administrative efficiencies, and it barred the board from rationing care, raising premiums or cost sharing, or reducing benefits.

The trigger mechanism was precise. Each year the chief actuary of the Centers for Medicare and Medicaid Services was to determine whether projected per-capita Medicare spending growth exceeded a target rate. For the early years the target was tied to a blend of medical inflation and general inflation; for later years the statute set the target at the growth rate of per-capita gross domestic product plus one percentage point. If the projection exceeded the target, the board was required to submit a proposal achieving the excess savings, with the proposal delivered to Congress and the president by a statutory deadline. Congress could then enact its own equivalent savings, in which case the board’s proposal fell away, or it could vote to override the proposal, but the override required a three-fifths supermajority in the Senate during a defined window. Failing either congressional action, the Secretary of Health and Human Services was required to implement the board’s proposal. The design was deliberate in its asymmetry: doing nothing meant the board’s savings took effect, so Congress had to act affirmatively to stop them. The supermajority override, in particular, drew constitutional and political criticism as an entrenchment device that bound future Congresses, though its defenders noted that any Congress could repeal the underlying statute by ordinary legislation, as eventually happened.

Opposition to the board began before the law’s ink was dry and never abated. Critics in Congress argued that the board concentrated too much power in an unelected body and that the fast-track procedures insulated its proposals from normal legislative deliberation. Physician groups and hospital associations objected that the board’s savings would inevitably fall on provider payment rates, since the statute barred the board from touching benefits, premiums, or cost sharing, leaving payment cuts as the principal available lever. Some defenders of the broader law shared the objection: members of Congress who had voted for the act nonetheless introduced legislation to repeal the board, arguing that Medicare payment policy belonged with elected legislators. The House of Representatives voted to repeal IPAB more than once in the years after enactment, though those repeal bills did not advance through the Senate. The board thus occupied a peculiar position in the law’s politics: it was one of the few provisions that drew sustained opposition from both the law’s critics and a meaningful faction of its supporters, which made its eventual repeal a matter of timing rather than of persuasion.

The board was never constituted. No president ever nominated its fifteen members, and the Senate therefore never confirmed anyone to it. The spending-growth trigger was never tripped in the years the board existed on paper, so no proposal was ever required, drafted, or submitted. The chief actuary of the Centers for Medicare and Medicaid Services issued the spending determinations the statute called for, and those determinations showed growth below the trigger thresholds. In practice IPAB was a contingency mechanism that the contingency never activated, and an institution that the appointing process never staffed. Its critics described it as an unelected board with power over Medicare spending; its defenders replied that it had never done anything at all and could not do anything unless spending growth exceeded the targets. Both descriptions were accurate, and they coexisted because the board lived entirely in the conditional tense.

The repeal came through the Bipartisan Budget Act of 2018, signed February 9, 2018. That legislation, a broad budget agreement, included the repeal of sections 3403 and 10320, ending the Independent Payment Advisory Board. The repeal had bipartisan support: opposition to the board had united critics of the broader law with some of its supporters in Congress who objected to the delegation of Medicare decisions to an appointed body and to the supermajority override requirement. The stated rationale of the repeal’s supporters was that an unappointed, unaccountable board should not hold automatic power over Medicare spending decisions, and that Congress should retain direct control of the program’s finances. That was their argument, and it is reported here as their argument rather than as this article’s judgment. The repeal attracted little of the drama that accompanied the repeal fights of 2017, in part because there was no board to defend, no members to dismiss, and no pending proposal to withdraw. Congress repealed an institution that had never been built.

The repeal’s placement inside the Bipartisan Budget Act of 2018 is itself informative. That act was a sweeping budget agreement that raised spending caps, extended a host of expiring provisions, and carried a long list of health policy riders. The IPAB repeal rode along as one of those riders, which meant it was never subjected to a standalone vote on its own merits in the form that repeal bills usually require. The budget agreement’s momentum carried provisions that might have stalled on their own, and the board’s repeal benefited from the dynamic: with bipartisan majorities already assembled for the underlying agreement, adding the repeal cost its supporters nothing. The same act also delayed the law’s tax on high-cost employer health plans and extended funding for the Children’s Health Insurance Program, a reminder that the amendment history ran in both directions even within a single enactment. Congress removed a cost-control mechanism and extended a coverage program in the same bill, a combination that captures the era’s ambivalence: skepticism of centralized savings machinery alongside continued commitment to the coverage the law had created.

There is a final irony in the board’s history that the record should preserve. The spending-growth trigger never fired during the board’s years on the books, which means the mechanism was repealed without ever being needed for its stated purpose. Medicare per-capita spending growth ran below the statutory targets through the period, a development that reflected the broader slowdown in health spending growth in the years after the law’s enactment. Defenders of the board argued that its mere existence had exerted a disciplinary effect on spending, a claim that is difficult to test and impossible to prove. Critics replied that a backstop that never engaged was a backstop in name only. Both positions were consistent with the observed facts, which is why the debate over the board’s repeal remained largely theoretical. What is certain is the institutional fact: sections 3403 and 10320 created a fifteen-member board, no member was ever appointed, no proposal was ever submitted, and the Bipartisan Budget Act of 2018 removed the sections from the law. The board that was never built was unbuilt by statute.

What remained of the law’s Medicare cost-control architecture after 2018 tells the reader where the real savings machinery lived all along. The act’s payment reforms, the reductions in annual updates to provider payment rates, the hospital readmissions reduction program, the value-based purchasing programs, and the accountable care organization models, all continued operating after the board’s repeal, and they had been producing savings throughout the board’s paper existence. The Center for Medicare and Medicaid Innovation, created by a separate section of the act, continued testing delivery and payment models. The board had been designed as a backstop for the contingency that these measures proved insufficient; the contingency never arrived, and the measures continued without it. The repeal thus removed a layer of the architecture that the architecture had never needed, which is the most charitable reading of the board’s history and also the most accurate one. Congress deleted a contingency, not a working program, and Medicare’s cost trajectory continued on the path set by the provisions that remained.

The bipartisan character of the repeal is the detail that future readers may find most surprising. The board had been one of the most politically charged provisions of the 2010 law, yet its repeal eight years later drew support from legislators across the spectrum, including members who had voted for the original act. The opposition that united them was institutional rather than ideological: a shared discomfort with delegating Medicare spending decisions to an appointed board whose proposals would take effect without an affirmative congressional vote. That discomfort crossed party lines because it was about congressional prerogative, the same prerogative that had produced the supermajority-override fight in the first place. In the end Congress reclaimed the power it had delegated, and the reclamation was quiet precisely because the delegation had never been exercised. The discomfort was institutional because the board’s design touched Congress’s own authority: the fast-track procedures and the supermajority override asked legislators to bind their successors, and legislators of both parties proved unwilling to leave that delegation standing once the spending trigger never fired. A mechanism that never operated offered no record for anyone to defend, and its repeal cost neither side a constituency, which is why a provision once among the most politically charged in the 2010 law could be removed eight years later with so little drama.

The significance of the IPAB repeal is easy to understate and worth stating carefully. Unlike the CLASS Act, which was repealed after being judged unworkable, IPAB was repealed without ever being tested. The spending trigger never fired, so the question of whether the board mechanism would have worked as designed, or whether Congress would have overridden its proposals, was never answered empirically. What the repeal did remove was a piece of the law’s cost-control architecture, the backstop that was supposed to guarantee Medicare savings if other measures failed. Its supporters in 2010 had presented it as a discipline device; its removal in 2018 left the law’s Medicare savings provisions resting on the payment reforms and delivery-system experiments that remained. The pattern of the CLASS repeal repeated with a variation: Congress again found it easier to delete a piece of the law than to operate it, and again the deletion targeted a mechanism that had no constituency of beneficiaries to defend it. Programs that pay claims acquire defenders. Mechanisms that exist on paper do not.

The Three Financing Taxes Repealed in 2019

This survey was first published in July 2011, when the Affordable Care Act was barely a year old. It was revised to carry the amendment record forward through 2022, with every change below tied to its dated enactment.

Why did three health taxes ride on an appropriations bill?

None of the three repeals passed as standalone health legislation. All three rode in Division N of the year-end funding measure signed December 20, 2019, which moved because the government had to be funded. Health provisions routinely ride such vehicles, and the repeals’ bipartisan coalitions made them natural passengers on must-pass legislation.

The Affordable Care Act of 2010 paid for its coverage expansion with a mix of spending reductions and new revenue. Among the revenue measures were several taxes and fees aimed at sectors of the health economy that the drafters expected to gain business from newly insured customers: generous employer health plans, device manufacturers, and private insurers. Those three measures became some of the most frequently revisited parts of the statute. Each was postponed at least once by later Congresses, and in December 2019 all three were removed in a single appropriations package.

The vehicle was the Further Consolidated Appropriations Act, 2020, signed on December 20, 2019. Division N of that law carried a set of health provisions, sometimes described as extenders, that repealed each of the three levies with its own effective date. The repeals were presented by their sponsors as corrections to taxes that had proved unworkable or economically harmful; critics of the repeals, including some supporters of the original law, argued that removing the revenue weakened the financing structure that had made the coverage expansion possible. Both positions are recorded here as stated positions, not as findings.

The first of the three was the excise tax on high-cost employer-sponsored coverage, codified at 26 U.S.C. 4980I and widely known as the Cadillac tax. As enacted, it imposed a 40 percent excise tax on the value of employer-sponsored health coverage above stated thresholds, originally set at 10,200 dollars for individual coverage and 27,500 dollars for family coverage in 2018 dollars, with the thresholds indexed to inflation in later years. The tax was to be paid by insurers and plan administrators rather than by workers directly, and it was scheduled to take effect in 2018. Its drafters intended it to do two things at once: raise revenue to help fund the coverage expansion, and discourage overly generous benefit designs that, in the view of many health economists, encouraged excess use of medical services. Whether that second purpose would have worked in practice was never tested, because the tax never took effect.

Congress postponed it twice. The Consolidated Appropriations Act, 2016, enacted in December 2015, pushed the effective date to 2020 and made the tax deductible for employers that paid it. A continuing resolution enacted in January 2018 pushed the date again, to 2022. Each delay reflected the same political pressure: labor unions, large employers, and benefits consultants argued that the thresholds would erode over time as health costs rose faster than general inflation, so that ordinary middle-income workers with standard plans would eventually be caught by a tax advertised as falling only on lavish executive benefits. The December 2019 repeal ended the cycle. The Cadillac tax was removed from the code before a single dollar of it was ever collected, making it one of the few major revenue provisions in modern tax history to be enacted, twice delayed, and then repealed without ever operating.

The sponsors of the repeal stated that taxing employer-provided health benefits would have forced employers to cut benefits or shift costs onto workers, and that the levy threatened a form of compensation that tens of millions of households relied upon. That rationale is reported as the sponsors stated it. Supporters of the original provision had argued the opposite, that the tax would restrain the growth of health spending and that its burden would fall mainly on high earners; that position is likewise recorded without endorsement.

The second repeal concerned the medical device excise tax, codified at 26 U.S.C. 4191. As enacted, it imposed a 2.3 percent excise tax on the sale price of taxable medical devices by manufacturers and importers, effective January 1, 2013. Certain retail devices and items sold directly to consumers were excluded, but the levy covered a broad range of equipment from imaging machines to surgical instruments. Unlike the Cadillac tax, this one actually operated: it was collected for the years 2013 through 2015. Congress then suspended it for 2016 and 2017 in the Consolidated Appropriations Act, 2016, and suspended it again for 2018 and 2019 in the January 2018 continuing resolution. The December 2019 law repealed it outright for sales after December 31, 2019, so no device tax was owed for 2020 or any later year.

The repeal’s sponsors stated that the tax had fallen heavily on smaller manufacturers, reduced spending on research and product development, and cost jobs in a domestic industry that faced foreign competition. Device industry groups had pressed that case for years, and repeal drew bipartisan votes in both chambers. As with the other repeals, the stated rationale is presented here without endorsement. Defenders of the original levy had argued that device makers would benefit from millions of newly insured customers and could reasonably contribute to the cost of the expansion; that position, too, is recorded as stated.

The third repeal ended the annual fee on health insurance providers, enacted as section 9010 of the Affordable Care Act. In operative terms, it was a fixed aggregate fee imposed each year on health insurers with net premiums written above 25 million dollars, allocated among those insurers in proportion to their market share. The aggregate amounts were set by statute: 8 billion dollars for 2014, 11.3 billion for 2015 and 2016, 13.9 billion for 2017, and 14.3 billion for 2018 and later years. The fee was not deductible as a business expense, which increased its effective cost to the companies that paid it. It took effect in 2014 and was collected for that year through 2016, then suspended for 2017 by the Consolidated Appropriations Act, 2016, collected again for 2018, and suspended again for 2019 by the January 2018 continuing resolution. The December 2019 law repealed the fee for calendar years beginning after December 31, 2020, which meant the 2020 fee was still collected and the levy ended with the 2021 plan year.

The sponsors of that repeal stated that insurers passed the fee through to customers in the form of higher premiums, so that repeal would lower premiums for households and small businesses. Insurer and business groups had made that pass-through argument since the fee’s inception. The rationale is reported as stated, without endorsement. Supporters of the original fee had argued that insurers were among the largest commercial beneficiaries of the coverage expansion and that a market-share fee was a fair way to have the industry help finance it; that position is recorded the same way.

The Cadillac tax also had an intellectual history that made its repeal a notable event in tax policy, not just health policy. The exclusion of employer-paid health premiums from taxable income is one of the largest tax expenditures in the federal code, and economists across the usual ideological spectrum had long argued that the open-ended exclusion encouraged overly generous coverage and inflated health spending. The 40 percent excise tax was the drafters’ indirect way of capping that exclusion without repealing it outright, which would have been politically impossible. Its repeal therefore closed off the most serious attempt any Congress had made to limit the exclusion, and tax policy specialists noted the outcome with interest: a levy designed by economists, enacted by a Democratic Congress, delayed twice, and finally repealed with bipartisan votes before collecting a dollar. The episode is often cited as evidence of how difficult it is to tax employer-provided health benefits in any form, however indirect.

The opposition that carried the repeal had a distinctive institutional base. Many of the loudest voices against the Cadillac tax were labor unions whose members held coverage through collectively bargained multiemployer plans, including building trades and public employee unions that otherwise supported the Affordable Care Act. Those unions argued that their members had traded wage increases for health benefits over decades of bargaining and would be punished for that choice if the tax took effect. Large employers, benefits consultants, and municipal governments made parallel arguments from the management side. The result was one of the stranger coalitions in the amendment history of the law: unions and employer groups, normally adversaries at the bargaining table, lobbying side by side for the same repeal, and winning.

The mechanics of the Cadillac tax explain why it drew such sustained opposition. The thresholds were set in 2018 dollars and indexed to the Consumer Price Index, while health costs historically rose faster than general inflation, so a growing share of plans would have crossed the threshold each year even without any change in benefit generosity. The statute provided somewhat higher thresholds for certain groups, including retirees not yet eligible for Medicare and workers in high-risk professions, with additional allowances of 1,650 dollars for individual coverage and 3,450 dollars for family coverage, but the basic design still meant that the tax would reach further down the income scale over time. Employers and unions argued that companies would respond long before 2018 by trimming benefits to stay under the thresholds, which meant workers would feel the tax as reduced coverage rather than as a line item. Whether employers would have done so, and whether that response would have slowed the growth of health spending as the drafters hoped, remains untested because the delays and then the repeal arrived before the first payment was ever due.

The medical device tax had a different history because it actually collected revenue before Congress set it aside. The Internal Revenue Service administered the 2.3 percent levy on manufacturers and importers, with an exemption for devices generally purchased by the public at retail for individual use, which kept items such as eyeglasses, contact lenses, and hearing aids outside the tax. For the three years it operated, 2013 through 2015, it raised a modest but real sum each year. The suspensions that followed were enacted as part of must-pass spending bills, which is how many of the law’s later changes were made: rather than amending the Affordable Care Act through standalone health legislation, Congress tucked delays and suspensions into appropriations and continuing resolutions. The Consolidated Appropriations Act, 2016 suspended the device tax for 2016 and 2017, and the continuing resolution of January 2018 extended the suspension through 2018 and 2019. By the time the December 2019 law repealed it for sales after December 31, 2019, the tax had been dormant for four years, and its repeal formalized a status quo that the suspensions had already created.

The insurer fee followed a similar arc of operation, suspension, and repeal. Its allocation formula counted only part of smaller insurers’ premiums: the first 25 million dollars of net premiums written were excluded entirely, premiums between 25 and 50 million dollars were counted at half value, and only premiums above 50 million dollars were counted in full, which concentrated the fee on larger carriers. Because the aggregate dollar amount was fixed by statute each year, the fee did not rise or fall with industry profits; it was a set sum divided among covered entities by market share. The nondeductibility provision made it more expensive in after-tax terms than an equivalent deductible expense. Insurers argued from the start that they would pass the cost to purchasers, and several states’ insurance regulators allowed the fee to be built into filed premium rates, which gave the pass-through claim visible support. The fee was collected for 2014 through 2016, suspended for 2017, collected for 2018, suspended for 2019, and collected one final time for 2020 before the repeal took hold for 2021 and later years.

The December 2019 repeals shared a legislative trait worth noting: none of them passed as a standalone health care bill. All three were carried in Division N of a year-end consolidated appropriations measure, the kind of legislation that moves because the government must be funded. Health extenders routinely ride on such vehicles, and the tax repeals were no exception. The votes were bipartisan in both chambers, reflecting coalitions that cut across the usual partisan divide on the Affordable Care Act: organized labor and large employers against the Cadillac tax, device manufacturers and their home-state delegations against the device levy, and insurers and business groups against the provider fee. That bipartisanship matters for the story of this article, because it shows that the rewriting of the law was not only the work of the statute’s opponents; provisions were also removed by lawmakers who otherwise supported the coverage expansion but objected to particular financing tools.

Taken together, the three repeals removed a meaningful share of the revenue that the 2010 law had counted on to offset its coverage costs. None of the three had ever functioned exactly as first written: one never took effect at all, one operated for only three of its first seven years, and one was collected in only four of its first seven years. Their removal by a single December 2019 enactment illustrates a pattern that runs through this article: provisions enacted by one coalition were dismantled piece by piece by later coalitions, often with bipartisan votes, and the dismantling was presented by its sponsors as fixing flawed taxes while opponents of repeal described it as eroding the law’s financing. The record supports both descriptions as statements of position; what is not in dispute is the operative result, which is that by the start of 2021 none of the three levies remained on the books.

The 2021 and 2022 Enlargement of the Premium Tax Credits

If the 2019 repeals showed the law being rewritten by subtraction, the legislation of 2021 and 2022 showed it being rewritten by addition. The premium tax credits, the mechanism by which the Affordable Care Act subsidized private insurance purchased through the exchanges, were temporarily enlarged first and then kept enlarged for a longer temporary period. The enlargement had a statutory end point, and describing it accurately requires keeping that end point in view: the credits were made more generous for defined years, not permanently restructured.

Why were the enlarged credits written to expire?

Both the 2021 and 2022 reconciliation laws faced the ten-year budget window that limits reconciliation provisions. Temporary provisions fit that framework more easily than permanent ones because their scored cost stops at the expiration date. The sponsors cited managing cost within those rules as the reason for the sunset.

To understand the change, it helps to recall how the credits worked as originally enacted. Households with incomes between 100 and 400 percent of the federal poverty level who purchased coverage through an exchange could receive advance premium tax credits that limited what they paid for the benchmark plan, defined as the second-lowest-cost silver plan in their area, to a set percentage of household income. The percentage rose with income, from about 2 percent at the bottom of the range to 9.5 percent at 400 percent of poverty. Above 400 percent of poverty, eligibility ended entirely, which created a sharp cliff: a household just below the line received help, while a household just above it, possibly earning only slightly more, received nothing. That cliff was one of the most criticized features of the original subsidy design, and the 2021 law addressed it directly.

The American Rescue Plan Act of 2021, signed on March 11, 2021, made three related changes to the credit schedule, all of them temporary and all of them applying to the 2021 and 2022 plan years. First, it eliminated the 400 percent of poverty cutoff. Households above that line became eligible for credits for the first time, with their required contribution for the benchmark plan capped at 8.5 percent of household income. A household earning well above the old cutoff could therefore receive a credit if the benchmark premium in its area exceeded 8.5 percent of its income, which in high-cost markets included many middle-income families who had previously been shut out entirely. Second, it lowered the required contribution percentages across the existing income bands. For households between 100 and 150 percent of poverty, the required contribution fell to zero, meaning the benchmark silver plan carried no premium for those enrollees. The percentages for the bands above that were reduced as well, so that households at every income level below the old cutoff paid less than the original schedule had required. Third, the law’s structure meant that the dollar value of credits rose mechanically wherever benchmark premiums were high, because the credit equals the difference between the benchmark premium and the household’s capped contribution.

The practical effect, as reported by the agencies that administered the exchanges, was a sizable drop in net premiums for subsidized enrollees and an increase in exchange enrollment during the years the enlarged credits applied. The sponsors of the 2021 provisions stated that the goal was to make coverage affordable for households that had been priced out, to smooth the cliff that had penalized small income gains, and to reduce the number of uninsured during the economic dislocation of the pandemic period. That rationale is reported as the sponsors stated it, without endorsement. Critics of the enlargement argued that extending credits above 400 percent of poverty directed public money to households that could afford coverage on their own and increased federal spending; that position is likewise recorded as stated.

The same 2021 law included a separate incentive aimed at the states that had not expanded Medicaid under the Affordable Care Act. Section 9814 of the American Rescue Plan offered any state that newly expanded Medicaid a temporary increase of five percentage points in its federal matching rate, applied to the state’s regular Medicaid spending for eight calendar quarters after expansion. In operative terms, the federal government would pick up a larger share of a newly expanding state’s existing Medicaid costs for two years, which the sponsors described as an offer designed to make expansion financially attractive to holdout states. The incentive was temporary by design: after the eight quarters, the matching rate would return to its normal level. Whether a state accepted the offer was left entirely to the state, and the provision created no penalty for declining.

The enlargement of the credits was written to expire after 2022, which set up the next legislative step. The Inflation Reduction Act of 2022, signed on August 16, 2022, extended the enlarged credit schedule through the 2025 plan year. Section 12001 of that law continued the same structure: no 400 percent of poverty cutoff, the 8.5 percent cap at the top of the income range, and the lowered contribution percentages in the lower bands. The extension was again temporary, with a defined statutory end point after 2025. It did not make the enlarged credits permanent, and any account that describes the 2021 changes as a permanent restructuring of the subsidy system is inaccurate. Congress chose a further temporary extension rather than a permanent rewrite, which left the long-term shape of the credits to be decided by a later Congress.

The sponsors of the 2022 extension stated that allowing the enlarged credits to lapse would have raised net premiums for millions of exchange enrollees and reversed the enrollment gains of the prior two years. That rationale is reported as stated, without endorsement. Opponents of the extension argued that the enlarged credits had been justified as pandemic relief and should not be continued once the emergency had passed, and that further extension added to federal deficits; that position is recorded the same way.

The credit system also had a tax-time mechanics that the 2021 law touched. Premium tax credits are advanceable: an enrollee estimates household income for the coming year, the Treasury pays the estimated credit directly to the insurer each month, and the household reconciles the difference on its tax return, repaying any excess if actual income came in higher than estimated. The American Rescue Plan added a one-year mercy rule to that reconciliation for tax year 2020: households that had received more in advance credits than their final 2020 income warranted were not required to repay the excess. The provision applied only to the 2020 tax year and was presented by its sponsors as relief for households whose incomes had swung unpredictably during the pandemic year. It is a small provision, but it belongs in the amendment record because it shows the same legislative instinct at work in miniature: the credit system was being made more forgiving, not merely more generous.

To feel the weight of the cliff’s removal, consider how the old cutoff worked in practice. Eligibility ended at 400 percent of the federal poverty level with no phaseout, so a household one dollar above the line received nothing while a household one dollar below it received a credit computed from the full schedule. In markets where the benchmark silver premium was high, which included many rural counties and several entire states, the dollar value of the lost credit could reach five figures a year, entirely on account of a trivial income difference. Financial planners had learned to counsel clients near the line to manage taxable income downward, through retirement contributions or timing of capital gains, to stay eligible. The 2021 law ended that game for the years it covered: above the old line, the contribution was simply capped at 8.5 percent of income, so help phased down smoothly as income rose rather than vanishing at a boundary. The change replaced a cliff with a slope, which was exactly how the sponsors described their intent.

One interaction the 2021 law inherited rather than designed was the benchmark premium’s already inflated state. Silver loading had been the industry’s standard response to the October 2017 end of cost-sharing reduction payments, and the second-lowest-cost silver plan, the benchmark against which every credit is calculated, therefore carried gross premiums well above what an unloaded schedule would have produced. The 2021 law layered its enlarged schedule onto those loaded benchmarks. Because the credit equals the benchmark premium minus the household’s capped contribution, and because the law lowered the caps while the benchmarks sat high, the dollar value of the credit grew from both directions at once: a smaller required contribution subtracted from a larger benchmark premium. In high-cost markets, where the benchmark premium already exceeded 8.5 percent of income for households well above the old 400 percent cutoff, newly eligible households could receive substantial credits at incomes that would have seemed far beyond subsidy range under the original design. The mechanism matters because neither feature alone would have produced the result. Without silver loading, the benchmarks would have been lower and the credits smaller; without the 8.5 percent cap, the higher benchmarks would not have translated into larger credits for the newly eligible. The combination was never planned as a pair. The October 2017 payment decision reflected one administration’s legal judgment about appropriations, and the March 2021 enlargement reflected a different Congress’s pandemic-era spending choices. But the credit formula’s arithmetic joined them, and the result was a subsidy schedule more generous in practice than either change would have produced alone. That generosity carried a scheduled end. The loaded benchmarks persisted as long as the payments stayed discontinued, while the enlarged caps were stamped to expire at the end of 2025.

The temporary character of the enlargement also reflected the legislative vehicle used to enact it. Both the American Rescue Plan Act and the Inflation Reduction Act moved through the budget reconciliation process, which allows revenue and spending legislation to pass the Senate with a simple majority but constrains provisions to effects within the ten-year budget window and subjects them to rules against increasing deficits beyond that window. Temporary provisions fit that process more easily than permanent ones, because their scored cost stops at the expiration date. The sponsors’ stated reason for writing the enlargement as temporary rather than permanent included managing its budgetary cost within the reconciliation framework; critics of the approach argued that everyone involved expected the temporary provisions to be extended, which made the stated cost an understatement. Both positions are recorded as stated. What matters for the amendment record is the operative consequence: the credit schedule lived under a countdown from the day it was enlarged, and its continuation depended on a future Congress acting before the clock ran out.

The Medicaid incentive in the 2021 law deserves a closer look at its mechanics, because the design was unusual. The five-percentage-point increase applied to the state’s regular federal matching rate, the rate that applies to the traditional Medicaid population, not to the 90 percent matching rate that already applied to the expansion population itself. In practical terms, the federal government offered to pay a larger share of what a newly expanding state was already spending on its existing Medicaid enrollees, for eight calendar quarters. For a state with a large existing program, that two-year bonus could amount to a substantial sum, which was precisely the sponsors’ stated intent: to make the fiscal case for expansion attractive even to legislatures that had resisted it for a decade. The offer was entirely voluntary, carried no penalty for declining, and expired on its own terms after the eight quarters. It was, in short, a time-limited bribe framed as fiscal prudence, or a prudent fiscal incentive framed as a bribe, depending on which side’s description one prefers; the mechanism itself is not in dispute.

The structure of the bonus repays attention because it reveals what the drafters thought the obstacle was. The expansion population itself already carried a 90 percent federal matching rate, so a state considering expansion was not being asked to fund the newly eligible at its normal share. The bonus instead attached to the state’s existing Medicaid spending, the traditional population the state was already covering at its regular matching rate, which meant the federal government was offering to relieve the state’s current budget rather than to subsidize the new one. For a state with a large existing program, two years of an additional five percentage points on that base translated into a substantial federal payment, which was the sponsors’ stated mechanism for changing the fiscal calculation in legislatures that had resisted expansion for a decade. The eight-quarter limit made the offer temporary by design: after two years the matching rate returned to normal, so a state that expanded kept the expansion population at the 90 percent rate but lost the bonus on its base spending. The provision asked nothing of states that declined and penalized none, which is why its effect depended entirely on whether the temporary bonus was large enough to move a legislature that a decade of the underlying 90 percent match had not moved.

The market response to the enlarged credits, as distinct from the sponsors’ hopes for them, played out through the exchanges in the 2021 and 2022 plan years. With benchmark plans carrying no premium for the lowest income band and lower net premiums across the schedule, exchange enrollment rose and several insurers that had withdrawn from markets in the leaner years returned or expanded their footprints. Those outcomes are described here as observed market behavior, not as verdicts on the policy. The same neutrality applies to the criticisms: that the enlarged credits subsidized households well up the income scale, that the temporary design created a coverage cliff of its own at the end of 2025, and that each extension would be harder to let lapse than the last, creating a ratchet that made temporary spending effectively permanent. All of those criticisms were stated by opponents of the enlargement and are recorded as stated.

Two features of this episode deserve emphasis for the article’s larger argument. First, the credit changes moved in the opposite direction from the tax repeals: they enlarged the law’s spending commitments rather than shrinking its revenue, and they were championed by the law’s supporters rather than its opponents. The amendment record of the Affordable Care Act is therefore not a single story of erosion but a two-sided one, with opponents removing financing provisions and supporters expanding subsidies, each side rewriting the statute toward its own ends. Second, the temporary character of both the 2021 enlargement and the 2022 extension meant that the credits existed in a state of scheduled uncertainty. Each extension required a new act of Congress, and the statute as it stood at the end of 2022 contained a more generous credit schedule with a printed expiration date. That is a distinctive way for a major entitlement provision to live: fully operative, widely used, and stamped with an end point that only further legislation could move.

The Inflation Reduction Act also contained other health provisions, most notably measures addressing prescription drug prices in Medicare, but those belong to the Medicare story rather than to the amendment history of the Affordable Care Act’s coverage provisions, and this article does not take them up. What belongs here is the credit schedule: enlarged for 2021 and 2022 by the March 2021 law, extended through 2025 by the August 2022 law, temporary throughout, and sponsored throughout by lawmakers who described the goal as keeping coverage affordable. The neutrality this article maintains toward the repeals applies equally to the enlargements: the sponsors’ stated purposes are reported, not endorsed, and the operative facts are what the record must carry.

Two Administrative Actions That Reshaped the Markets

Not every amendment to the Affordable Care Act came from Congress. Two of the most consequential changes to how the law operated in practice were made by the executive branch: the discontinuation of direct cost-sharing reduction payments to insurers in October 2017, and the successive revisions of the religious and moral exemptions from the contraceptive coverage requirement across 2017 and 2018. Neither altered the statute’s text, but each altered the law’s lived operation, and the amendment record is incomplete without them.

The cost-sharing reduction payments were part of the law’s original design for helping lower-income households afford care. Enrollees with household incomes between 100 and 250 percent of poverty who chose silver-tier plans were entitled by statute to reduced deductibles, copayments, and out-of-pocket maximums, and the federal government was to reimburse insurers for the cost of providing those reductions. For the law’s first years, the payments flowed. Then a legal dispute arose over whether Congress had ever appropriated the money: the House of Representatives sued, a federal court held that the payments lacked a valid appropriation, and the executive branch continued the payments while the case was on appeal. On October 12, 2017, the administration announced that the payments would stop, citing the Justice Department’s view that no appropriation existed to support them. The underlying statutory obligation on insurers to provide the reduced cost sharing to eligible enrollees did not change; what changed was that insurers would no longer be reimbursed directly for doing so.

The market response is the part of this episode that belongs in an amendment history, because it permanently changed how premiums were set. Insurers, facing unreimbursed costs they were still legally required to bear, raised premiums to cover them. Most state regulators allowed insurers to concentrate those increases in silver-tier plans, the only tier where the cost-sharing reductions applied. This practice became known as silver loading. Because premium tax credits are calculated from the price of the benchmark silver plan, the second-lowest-cost silver plan in each area, raising silver premiums mechanically increased the dollar value of the credits. The mechanism worked as follows: a higher benchmark premium widened the gap between that premium and each subsidized household’s capped contribution, and the credit filled the wider gap. For enrollees who received credits, net premiums therefore often fell even as gross premiums rose, and many could apply the enlarged credit to bronze or gold plans and pay less than before. For enrollees without credits, who paid the full gross premium, the silver-loaded increases were a straightforward price rise with no offsetting help.

The secondary effects were substantial and are described here as mechanics, not as judgments. Federal spending on premium tax credits rose because the credits were larger, which meant the government ended up paying more through the credit channel than it had been paying through the discontinued reimbursement channel, according to analyses published at the time. Enrollment patterns shifted as subsidized buyers took advantage of lower net premiums. None of this required any act of Congress; it followed from the interaction between the October 2017 payment decision and the statutory formula that ties credits to the benchmark silver premium. The episode demonstrates how an administrative action, combined with the law’s own arithmetic, can rewrite outcomes as thoroughly as a statutory amendment.

The second administrative action concerned the contraceptive coverage requirement and unfolded in two rulemaking rounds. The Affordable Care Act required most employer health plans to cover preventive services without cost sharing, and the Health Resources and Services Administration defined that category to include contraceptive methods. The original regulations offered an accommodation for religious nonprofit employers, allowing them to opt out while their insurers or plan administrators provided the coverage separately, but houses of worship were the only entities fully exempt. That compromise satisfied few of its critics, and litigation over the accommodation continued for years.

In October 2017, the administration issued two interim final rules that substantially widened the available exemptions. In operative terms, the rules permitted employers with sincerely held religious beliefs to claim an exemption from the contraceptive coverage requirement, and they created a new exemption for entities with sincerely held moral convictions against contraceptive coverage, extending that moral exemption to nonprofit organizations and to closely held for-profit companies. The rules also made the existing accommodation process optional rather than mandatory for exempt entities. The stated rationale of the rulemakers was that the prior accommodation still burdened religious exercise and that entities with moral objections deserved parallel treatment; that rationale is reported as stated, without endorsement.

Final rules followed in November 2018, published on November 15, 2018 and effective January 14, 2019, largely retaining the interim framework with clarifications. Under the final rules, the religious exemption was available to employers, including publicly traded companies, with sincerely held religious beliefs opposed to contraceptive coverage. The moral exemption was available to nonprofit entities and to for-profit entities without publicly traded ownership interests whose sincerely held moral convictions opposed coverage; publicly traded for-profit companies could not claim the moral exemption. Entities that claimed an exemption were not required to use the accommodation process, though the accommodation remained available for those that did not claim an exemption. Several states challenged the rules in court, and the Supreme Court upheld the rulemaking authority behind them in July 2020 in litigation brought by Pennsylvania. The operative result, from late 2018 forward, was that the contraceptive coverage requirement applied to a narrower set of employers than the original regulations had contemplated, with the exemptions defined by the employer’s stated beliefs rather than by its tax status alone.

The payment dispute had a longer backstory than the October 2017 announcement suggests. The House of Representatives had sued in 2014, arguing that the executive branch was spending money Congress had never appropriated, and in May 2016 a federal district court agreed, holding that the cost-sharing reduction payments lacked a valid appropriation while staying its own order pending appeal. The Obama administration continued the payments during the appeal, and the incoming administration continued them through most of 2017 while its lawyers reviewed the question. Insurers setting 2018 premiums in the spring and summer of 2017 therefore faced a genuine uncertainty: they did not know whether the reimbursements would survive the year. Many state insurance regulators responded pragmatically, instructing insurers to assume the payments would end and to price silver plans accordingly, or to file two sets of rates, one with the payments and one without. By the time the October 12, 2017 announcement arrived, just weeks before the November 1 start of open enrollment for the 2018 plan year, silver loading was already largely baked into filed premiums. The administrative action confirmed what the market had priced in rather than surprising it.

The calendar is what makes this episode an administrative action rather than a mere legal conclusion. The May 2016 district court order was stayed pending appeal, so the payments continued through the 2016 plan year and most of 2017 while the new administration’s lawyers reviewed the appropriation question. Insurers had to file 2018 rates in the spring and summer of 2017, months before the October 12 announcement, which meant every filing was a bet on a legal question no court had finally resolved. State regulators, who approve the rates, split the difference pragmatically: many told insurers to price as though the payments would end, and several allowed dual filings, one rate assuming the reimbursements continued and another assuming they stopped. The October announcement therefore landed on a market that had already adapted. By the time open enrollment for the 2018 plan year began on November 1, 2017, the silver-loaded premiums were filed, approved, and displayed to shoppers. The executive branch had changed the law’s operation, but the market had priced the change in advance.

The fiscal irony of the episode was identified before it happened. In August 2017, the Congressional Budget Office analyzed what ending the payments would do and concluded that federal deficits would rise, not fall, because the larger premium tax credits produced by silver loading would cost the Treasury more than the discontinued reimbursements had. No exact figure is needed to grasp the mechanism: every dollar added to the benchmark silver premium increased the credit for every subsidized enrollee in that market, while the discontinued payments had reimbursed only the cost-sharing of the eligible subset. The administration’s stated reason for ending the payments was legal rather than fiscal, namely the Justice Department’s conclusion that no appropriation supported them, and that rationale is reported as stated. The fiscal consequence, whatever the legal merits, was that the federal government spent more to support the exchanges after the payments stopped than it had spent while they flowed.

The contraceptive exemption rules had their own layered history. The accommodation the rules displaced worked through a self-certification process: an objecting religious nonprofit notified its insurer or third-party administrator, using a form administered by the Labor Department, and the insurer or administrator then provided contraceptive coverage separately without cost sharing and without the employer’s involvement or funding. Many religious employers argued that even this indirect facilitation violated their beliefs, and the resulting litigation reached the Supreme Court twice before the 2017 rules were issued. The interim final rules of October 2017 were issued with a request for public comment rather than through the full notice-and-comment process that normally precedes major rules, which became one of the grounds on which states challenged them. The final rules of November 2018, published November 15, 2018 and effective January 14, 2019, went through the complete rulemaking process and largely retained the interim framework while responding to comments. Pennsylvania and other states sued to block both sets of rules, and in July 2020 the Supreme Court upheld the administration’s authority to issue them, in a 7 to 2 decision in the case brought by the Little Sisters of the Poor. The operative result from late 2018 forward was as described above: exemptions defined by sincerely held religious or moral objection, available without the accommodation process, and drawn more broadly than the original regulations had allowed.

The two earlier Supreme Court engagements explain the shape of what followed. The accommodation the 2017 rules displaced had itself been the subject of years of litigation, reaching the Supreme Court twice before the interim rules were issued, because many religious employers argued that even the self-certification step made them complicit in coverage they opposed. The interim final rules of October 2017 were issued with a request for public comment rather than through the full notice-and-comment process that normally precedes major rules, a procedural shortcut that became one of the grounds on which Pennsylvania and other states challenged them. The final rules of November 2018 went through the complete rulemaking process, closing the procedural gap while retaining the interim framework. When the Supreme Court upheld the administration’s rulemaking authority in July 2020, in the 7 to 2 decision in the case brought by the Little Sisters of the Poor, the holding addressed the authority to issue the rules rather than the wisdom of the exemptions themselves.

Both administrative actions share a feature with the statutory amendments traced earlier in this article: they were dated, deliberate, and outcome-changing, and they were made by actors other than the coalition that wrote the original law. The October 2017 payment decision came from an administration that opposed the statute, while the credit enlargements of 2021 and 2022 came from administrations and Congresses that supported it. The amendment history of the Affordable Care Act is therefore the work of both its friends and its adversaries, each using the tools available to them, legislation for some changes and executive action for others, to move the operating law away from the enacted text.

The Amendment Ledger

Year	Amending statute	Provision affected	Type	Operative status
2011	Department of Health and Human Services announcement, October 2011	Community Living Assistance Services and Supports program	administrative action	Implementation suspended after the department concluded it could not certify the program as actuarially sound
Early 2013	American Taxpayer Relief Act of 2012, signed January 2, 2013	Community Living Assistance Services and Supports program	repeal	Title VIII repealed outright, ending the long-term care program before it enrolled anyone
2017	Tax Cuts and Jobs Act, signed December 22, 2017	Shared responsibility payment, 26 U.S.C. 5000A	reduction to zero	Payment amount reduced to zero effective 2019, leaving the provision in the code with no operative penalty
2018	Bipartisan Budget Act of 2018, signed February 9, 2018	Independent Payment Advisory Board	repeal	Board abolished before it ever issued a recommendation or exercised any authority
2019	Further Consolidated Appropriations Act, 2020, signed December 20, 2019	Excise tax on high-cost employer coverage, 26 U.S.C. 4980I	repeal	Repealed before taking effect, after postponements first to 2020 and then to 2022
2019	Further Consolidated Appropriations Act, 2020, signed December 20, 2019	Medical device excise tax, 26 U.S.C. 4191	repeal	Repealed for sales after December 31, 2019, following suspensions covering 2016 through 2019
2019	Further Consolidated Appropriations Act, 2020, signed December 20, 2019	Annual fee on health insurance providers, ACA section 9010	repeal	Repealed for calendar years beginning after December 31, 2020, with the 2020 fee still collected
2021	American Rescue Plan Act of 2021, signed March 11, 2021	Premium tax credit schedule	expansion	Credits enlarged for 2021 and 2022, with the 400 percent of poverty cutoff removed and benchmark contributions capped at 8.5 percent of income
2022	Inflation Reduction Act of 2022, signed August 16, 2022	Premium tax credit schedule	expansion	Enlarged schedule continued through 2025, remaining temporary with a defined statutory end point
2017	Executive action announced October 12, 2017	Direct cost-sharing reduction payments to insurers	administrative action	Payments discontinued while the underlying insurer obligation continued, prompting concentrated premium increases in silver-tier plans that enlarged benchmark-linked credits
2017-2018	Interim final rules October 2017, final rules November 2018	Contraceptive coverage requirement	administrative action	Religious and moral exemptions widened so that objecting employers could opt out without using the accommodation process

Verdict

The namable claim of this article is the hollowing pattern. The Affordable Care Act was never repealed. No Congress assembled the votes to strike the statute from the books, and the law’s central coverage machinery, the exchanges, the premium tax credits, the Medicaid expansion, the insurance market rules, continued to operate through every year covered here. But the statute was substantially rewritten by subtraction, and the operative law at the end of 2022 differed from the enacted law of 2010 more than is true for any other statute in this series.

Count what was removed. An entire title of the act, Title VIII, the Community Living Assistance Services and Supports program, was suspended in 2011 and repealed in early 2013. A freestanding institution created by the act, the Independent Payment Advisory Board, was abolished in 2018 before it ever acted. Three dedicated revenue measures, the excise tax on high-cost employer coverage, the medical device excise tax, and the annual fee on health insurance providers, were repealed in a single December 2019 enactment, one of them before it ever took effect. One enforcement mechanism, the shared responsibility payment, was reduced to zero effective 2019, leaving a mandate on the books with no penalty behind it. And two administrative actions, the October 2017 discontinuation of cost-sharing reduction payments and the 2017 to 2018 widening of contraceptive coverage exemptions, changed how the law worked without changing its text. That is the ledger: a title, a board, three taxes, one enforcement mechanism, and two operating rules, all gone or transformed within a dozen years of enactment.

The pattern is distinctive because the rewriting came from both directions. The subtractions, the repeals of the CLASS program, the board, the taxes, and the penalty, were the work of the law’s opponents and of bipartisan coalitions that objected to particular provisions while accepting the rest. The additions, the temporary enlargement of the premium tax credits in 2021 and their extension through 2025 in 2022, were the work of the law’s supporters, who used the same amendment process to make the statute more generous rather than less. Few statutes in this series have been pulled at from both ends with such persistence. Most laws in these pages were amended by their friends to fix defects or extend their reach; a smaller number were attacked by their enemies and survived intact. The Affordable Care Act is the rare case that was simultaneously eroded and enlarged, so that the 2022 version was both smaller in its financing and larger in its subsidies than the 2010 original.

This is the fourth stage in a statute’s life, and the series thesis thread runs directly through it. The first stage is enactment, when a coalition writes its ambitions into law. The second is implementation, when agencies and courts discover what the text actually does. The third is contestation, when opponents try to repeal or hollow out what was built. The fourth is settlement by amendment, when the statute stops being the thing that was enacted and becomes the thing that successive coalitions have made of it, with each side’s changes layered over the other’s. The Affordable Care Act reached that fourth stage faster and more visibly than most laws in this series. By 2022 it was a palimpsest: the 2010 text still visible underneath, but the operating provisions above it written by the Congresses of 2013, 2017, 2018, 2019, 2021, and 2022, and by two administrations acting through regulation and executive decision.

The comparison with other statutes in this series sharpens the point. Most of the laws covered in these pages were amended mainly by their friends: supporters returned to fix drafting errors, extend expiring authorities, or broaden benefits, while opponents, having lost the enactment fight, moved on. A few were amended mainly by their enemies and survived by inertia. The Affordable Care Act stands nearly alone in having been continuously rewritten by both camps at once, with each side’s amendments layered directly over the other’s. The 2019 tax repeals and the 2021 credit enlargement were enacted barely a year apart, by different coalitions, moving the same statute in opposite directions. That is why the hollowing pattern deserves its name: the law was not simply eroded, and it was not simply improved. It was hollowed in its financing and filled out in its benefits at the same time, leaving a structure that neither its drafters nor its opponents had designed.

The verdict, stated plainly, is that repeal failed but revision succeeded. The opponents of the law never mustered the votes to end it, yet they removed much of what made it the law its drafters had written. The supporters of the law never secured its original financing design, yet they expanded its benefits beyond what the 2010 text had promised. What remains is neither the statute that was signed in March 2010 nor the absence of a statute that repeal would have produced. It is a third thing: a law rewritten by subtraction and addition alike, carrying the fingerprints of everyone who touched it, and standing as the clearest example in this series of how American statutes are truly made, not once at enactment but continuously, amendment by amendment, for as long as the law stands. The lesson the sequence teaches is that a statute’s survival and a statute’s stability are different things. The law survived every attempt to end it, yet the law that survived is not the law that was enacted. Each Congress that touched the statute left its own layer, and the layers do not reconcile into a single design. What stands is a working settlement among successive amendments, legible only through the dates attached to each change.

Study: Keeping the Amendment Timeline

For readers working through this series as a course of study, the amendment history above repays careful note-taking, because the dates are the argument: a 2011 suspension, a 2013 repeal, a 2017 zeroing and payment decision, a 2018 board repeal, three 2019 tax repeals, a 2021 enlargement, and a 2022 extension form a sequence that is easy to scramble and worth keeping straight. One practical method is to copy the ledger table into a personal study notebook and annotate each row with the statute’s public law number and the operative effective date, so that the timeline can be rehearsed from memory rather than re-read each time. A second method is to draft two columns, the law as enacted in 2010 and the law as it operated at the end of 2022, and to place each amendment as a bridge between them, which makes the hollowing pattern visible at a glance. A third is to sort the eleven changes by the coalition that made them, supporters or opponents, and to notice how evenly the work divides. A structured notebook for that kind of legislation study, with space for timelines and citation lists, is available at the VaultBook legislation study notebook, which suits the task of keeping eleven dated changes and their citations in order. The habit matters beyond this article: every statute in this series has an amendment history, and the student who tracks the dates will always understand the law better than the student who remembers only the enactment year. A final exercise carries the article’s thesis into the rest of the series. Take any other statute covered in these pages and ask the fourth-stage question: who has amended it since enactment, from which side, and does the operating law still resemble the enacted text? For most statutes the answer will be reassuring, a few friendly amendments and the original design intact. The Affordable Care Act is the case that teaches the question, because its answer is so striking: amended by friends and adversaries alike, hollowed in its financing, enlarged in its benefits, and still standing under a name that by the end of 2022 described a different law than the one enacted in 2010.

Frequently Asked Questions

Q: Has the Affordable Care Act been repealed?

No. As of 2022, Congress has never passed a law repealing the Affordable Care Act, and no court has struck it down in full. What happened instead is narrower: Congress removed or defused individual pieces through later legislation. The most frequently misunderstood example is the Tax Cuts and Jobs Act of 2017, which reduced the shared responsibility payment under section 5000A to zero dollars and zero percent effective for months after December 31, 2018. That change ended the financial enforcement of the coverage requirement but left the requirement’s statutory text in place, and it left every other title of the law untouched. Other pieces were repealed outright: the CLASS Act in early 2013, the Independent Payment Advisory Board in 2018, and three health-related taxes in 2019. None of these were repeals of the statute itself. The exchanges, the market rules, the Medicaid expansion, and the premium tax credits all continued to operate, which is why describing the law as repealed is inaccurate even though describing it as amended is correct.

Q: What did the 2017 tax law change in the Affordable Care Act?

The Tax Cuts and Jobs Act, signed December 22, 2017, made one surgical change to the Affordable Care Act’s operating machinery: it reduced the shared responsibility payment in 26 U.S.C. 5000A to zero dollars and zero percent of household income for months beginning after December 31, 2018. The payment had been the enforcement mechanism behind the law’s individual coverage requirement, calculated as the greater of a flat dollar amount or a percentage of income above the filing threshold. By zeroing both figures, Congress ended the financial penalty for going without coverage while leaving the coverage requirement’s statutory text intact. The distinction matters because it shaped everything that followed: with the requirement still on the books but unenforced, the law’s other provisions, the exchanges, subsidies, and market rules, continued to function, and the zeroing became the trigger for the standing dispute that ended the California v. Texas challenge in 2021.

Q: Is the Affordable Care Act individual mandate penalty still in effect?

In the text of the statute, yes: section 5000A still directs individuals to maintain minimum essential coverage, because the 2017 law changed only the payment amount and never repealed the requirement itself. In practical terms, however, the requirement has had no enforcement since the payment went to zero for months after December 31, 2018. Nobody owes anything for noncompliance, and no agency collects anything under that section. For readers checking the law as it stood at the end of 2022, the distinction matters: the mandate was defused rather than deleted. A future Congress could restore a nonzero payment without rewriting the requirement, precisely because the requirement was never taken off the books. Understanding the mandate’s status as operative in text but unenforced in practice is essential to understanding why the law’s coverage machinery kept functioning after 2019 without it.

Q: Was the Affordable Care Act Independent Payment Advisory Board ever created?

The Independent Payment Advisory Board was repealed before it ever did anything. Created by sections 3403 and 10320 of the Affordable Care Act as a fifteen-member body that could recommend Medicare spending reductions if per-capita spending exceeded targets, IPAB was one of the law’s most controversial paper institutions. But no president ever nominated members, the Senate never confirmed any, and the board never issued a recommendation, largely because Medicare spending growth stayed below the statutory triggers through the 2010s. The Bipartisan Budget Act of 2018, signed February 9, 2018, repealed the IPAB provisions outright. Its abolition drew little public notice because there was nothing operational to dismantle: no staff, no rulings, no savings. What Congress removed was a dormant authority, not a functioning program, and the board’s story is better understood as an experiment in institutional design that the political system abandoned than as a battle over Medicare policy. It does not sit dormant in any sense; it was abolished outright in 2018 and is simply gone.

Q: What was the CLASS Act in the Affordable Care Act and why was it dropped?

The CLASS Act was Title VIII of the Affordable Care Act, a voluntary federal long-term care insurance program financed entirely by enrollee premiums. Workers who paid in for five years would have qualified for a cash benefit, averaging at least fifty dollars a day, to help with daily living needs. On October 14, 2011, the Secretary of Health and Human Services suspended implementation after the department concluded that no actuarially sound benefit plan could be designed within the statute’s constraints: voluntary enrollment, guaranteed issue without underwriting, a five-year vesting period, and a requirement that the program be self-financing over seventy-five years. The combination invited adverse selection, healthier people would stay out while likely claimants enrolled, making premiums unaffordable. Congress repealed Title VIII in the American Taxpayer Relief Act of 2012, signed January 2, 2013. No one ever enrolled, no premium was collected, and no benefit was paid: an entire title of a landmark statute that never operated.

Q: What did the American Rescue Plan change about Affordable Care Act subsidies?

The American Rescue Plan Act of 2021, signed March 11, 2021, temporarily enlarged the premium tax credits for the 2021 and 2022 plan years in three ways. First, it eliminated the 400 percent of federal poverty level income cutoff, so households above that line could receive credits for the first time, with their required contribution for the benchmark plan capped at 8.5 percent of household income. Second, it lowered the required contribution percentages across the existing income bands, bringing the contribution to zero for households between 100 and 150 percent of poverty. Third, because the credit equals the difference between the benchmark premium and the household’s capped contribution, the dollar value of credits rose mechanically wherever benchmark premiums were high. The law also offered states that newly expanded Medicaid a temporary five-percentage-point increase in their regular federal matching rate for eight calendar quarters. All of the credit changes were temporary by design.

Q: What did the Supreme Court decide in California v. Texas?

In California v. Texas, decided June 17, 2021, the Supreme Court did not decide whether the individual coverage requirement was constitutional. It decided that the challengers, a group of states and individuals, lacked standing to sue. After the 2017 tax law zeroed the shared responsibility payment, the plaintiffs could point to no enforcement injury: nobody owed anything under section 5000A, so nobody could claim the kind of concrete harm that federal courts require. Justice Breyer’s majority opinion held that the challengers had not shown the provision injured them, which meant the Court could not reach the merits of the constitutional question. Two justices dissented. The practical result was that the Affordable Care Act survived its third major Supreme Court challenge without the Court ever ruling on whether a coverage requirement without any payment could stand on its own. The case turned entirely on who may sue, not on what the law means.

Q: Which Affordable Care Act taxes have been repealed?

Three. The Further Consolidated Appropriations Act, 2020, signed December 20, 2019, repealed the excise tax on high-cost employer-sponsored coverage, known as the Cadillac tax and codified at 26 U.S.C. 4980I; the 2.3 percent medical device excise tax at 26 U.S.C. 4191; and the annual fee on health insurance providers enacted as section 9010 of the act. Each had a different history before repeal: the Cadillac tax, a 40 percent levy on coverage value above set thresholds, was postponed twice and never collected a dollar; the device tax operated from 2013 through 2015 and was suspended for 2016 through 2019; the insurer fee was collected for 2014 through 2016 and 2018, suspended for 2017 and 2019, and collected one final time for 2020 before the repeal took effect for calendar years beginning after December 31, 2020. The repeals were bipartisan and arrived as riders on a year-end appropriations measure, reflecting coalitions, unions and employers against the Cadillac tax, manufacturers against the device levy, that cut across the usual partisan lines.

Q: Why did insurers raise premiums after cost-sharing reduction payments ended?

Because the law’s arithmetic left them no choice. Cost-sharing reductions were discounts on deductibles and copayments that the statute required insurers to give lower-income silver-plan enrollees, and the federal government had reimbursed insurers for providing them. When the administration discontinued direct payments on October 12, 2017, citing the absence of a congressional appropriation, the insurers’ legal obligation to provide the discounts did not change, but the reimbursement stopped. Insurers therefore raised premiums to cover costs they were still required to bear. Most state regulators let them concentrate those increases in silver-tier plans, the practice known as silver loading, since only silver plans carried the reductions. Because premium tax credits are calculated from the benchmark silver premium, the higher silver prices mechanically increased credit amounts, which often lowered net premiums for subsidized enrollees even as gross premiums rose. Unsubsidized enrollees paid the full increase.

Q: What happened to the Affordable Care Act Cadillac tax?

They were different levies aimed at different parts of the health economy, though both were enacted as financing measures in the 2010 law and both were repealed by the December 2019 appropriations act. The Cadillac tax, codified at 26 U.S.C. 4980I, would have imposed a 40 percent excise tax on the value of employer-sponsored health coverage above set thresholds, originally 10,200 dollars for individual and 27,500 dollars for family coverage in 2018 dollars, paid by insurers and plan administrators. It was postponed twice and never took effect, so it never collected a dollar. The medical device tax, at 26 U.S.C. 4191, imposed a 2.3 percent excise tax on manufacturers’ and importers’ sales of taxable medical devices, took effect January 1, 2013, operated through 2015, and was suspended for 2016 through 2019. One was a tax on generous benefits that died before birth; the other was a tax on device sales that lived, slept, and was then abolished.

Q: How did the contraceptive coverage rules change after 2016?

Through two rounds of rulemaking in 2017 and 2018. The Affordable Care Act required most employer health plans to cover preventive services without cost sharing, and regulators defined that to include contraceptives. The original accommodation let religious nonprofits opt out while their insurers provided the coverage separately. On October 6, 2017, the administration issued interim final rules, published October 13, 2017, that widened the exemptions: employers with sincerely held religious beliefs could claim exemption, and a new exemption covered entities with sincerely held moral convictions, extended to nonprofits and closely held for-profit companies. The accommodation became optional rather than mandatory for exempt entities. Final rules issued November 7, 2018, and published November 15, 2018, largely retained that structure. The changes were immediately litigated, and the Supreme Court upheld the agencies’ authority to issue the rules in a 2020 decision, though that ruling addressed the rulemaking power rather than settling every challenge to the exemptions’ scope.

Q: Did the 2017 repeal attempts succeed?

No. In the spring and summer of 2017, Congress considered a series of measures that would have repealed or fundamentally restructured the Affordable Care Act: the American Health Care Act passed the House, and the Senate took up the Better Care Reconciliation Act, the Obamacare Repeal Reconciliation Act, and finally the Health Care Freedom Act, the so-called skinny repeal, which failed 49 to 51 on July 28, 2017. None became law. The only 2017 legislation that actually amended the statute was the Tax Cuts and Jobs Act, signed December 22, 2017, and its change was the zeroing of the shared responsibility payment, not a repeal of any title. The confusion is understandable, because the repeal drama dominated the year’s headlines while the tax act’s single operative change to the health law received comparatively little attention. But the legislative record is unambiguous: the repeals failed, and the zeroing succeeded.

Q: What survived of Title VIII after the CLASS Act was repealed?

Nothing of the program, but the episode left traces in the statute’s history. The American Taxpayer Relief Act of 2012, signed January 2, 2013, repealed Title VIII outright, removing the Community Living Assistance Services and Supports provisions from the code. No premiums had ever been collected and no benefits paid, so there was no wind-down to administer and no enrollees to transition. The long-term care financing gap that motivated the title persisted: Medicaid continued as the dominant payer for formal long-term care, and no federal replacement for CLASS was enacted within this article’s horizon through 2022. What survived was procedural memory. The CLASS repeal demonstrated that a title of a landmark law could be removed inside a tax bill with minimal debate when the provision had no beneficiaries to defend it, a lesson Congress applied with far greater consequence in the 2017 zeroing of the shared responsibility payment.

Q: Are the enlarged premium tax credits permanent?

No. The American Rescue Plan Act of 2021 enlarged the credits only for the 2021 and 2022 plan years, and the Inflation Reduction Act of 2022, signed August 16, 2022, extended the enlarged schedule only through the 2025 plan year. Both laws wrote the enlargement as temporary, with a defined statutory end point after 2025. The temporary design was partly a product of the budget reconciliation process, under which both laws passed: temporary provisions fit the ten-year budget window more easily than permanent ones, since their scored cost stops at the expiration date. The practical consequence was scheduled uncertainty: the more generous credit schedule was fully operative and widely used, but it carried a printed expiration date that only further legislation could move. Any account describing the 2021 changes as a permanent restructuring of the subsidy system is inaccurate for the period this article covers.

Q: What did the 2022 law extend, and through what year?

The Inflation Reduction Act of 2022, signed August 16, 2022, extended the enlarged premium tax credit schedule created by the American Rescue Plan through the 2025 plan year. Section 12001 of the law continued the same structure: the 400 percent of poverty income cutoff stayed removed, the required contribution for the benchmark plan stayed capped at 8.5 percent of household income at the top of the range, and the lowered contribution percentages in the lower income bands stayed in place. The extension was again temporary, with a defined statutory end point after 2025, and it did not make the enlarged credits permanent. The law also contained other health provisions, most notably measures addressing prescription drug prices in Medicare, but those belong to the Medicare story rather than to the amendment history of the Affordable Care Act’s coverage provisions, and this article does not take them up.

Q: What incentive did the 2021 law offer states that had not expanded Medicaid?

A temporary increase in federal matching funds. Section 9814 of the American Rescue Plan Act of 2021 offered any state that newly expanded Medicaid a five-percentage-point increase in its regular federal matching rate, applied to the state’s existing Medicaid spending for eight calendar quarters after expansion. In practical terms, the federal government would pay a larger share of what the state was already spending on its traditional Medicaid population for two years, a bonus the sponsors described as making expansion financially attractive to holdout states. The increase applied to the regular matching rate, not to the 90 percent rate that already covered the expansion population itself. The offer was entirely voluntary, carried no penalty for declining, and expired on its own terms after the eight quarters. It was a time-limited fiscal inducement, framed by supporters as prudence and by critics as a bribe; the mechanism itself is not in dispute.

Q: How does the law as it operated at the end of 2022 differ from the law as enacted in 2010?

It is the same statute with different plumbing. Eleven dated changes separate the two versions. On the subtraction side, Title VIII is gone entirely, repealed in 2013; the shared responsibility payment is zero, defused in 2017; the Independent Payment Advisory Board is abolished, repealed in 2018; and three financing taxes, the Cadillac tax, the device tax, and the insurer fee, are repealed as of 2019. The administrative record adds the discontinued cost-sharing reduction payments of 2017 and the widened contraceptive exemptions of 2017 and 2018. On the addition side, the premium tax credits are more generous than the original design, enlarged in 2021 and extended through 2025. The core remains: the exchanges, the market rules, the Medicaid expansion, and the subsidies all operate. What changed is the financing architecture around them, hollowed by repeals, and the generosity of the credits, enlarged by supporters. A reader who knows only the 2010 text would recognize the 2022 law’s skeleton but misjudge its mechanics.

Q: What does “hollowed by subtraction” mean in this article’s verdict?

It describes the article’s central claim about the amendment record. “Hollowed” refers to the financing provisions that Congress removed: Title VIII’s projected premium revenue, the shared responsibility payment, the three health taxes, and the direct cost-sharing reduction payments, all of which had helped fund or enforce the coverage expansion. “By subtraction” distinguishes this method from wholesale repeal. Congress never voted the statute down; instead, successive Congresses took individual pieces away, each removal aimed at a discrete, severable component that could be detached without disturbing the exchanges, the market rules, or the Medicaid expansion. The verdict pairs the phrase with its mirror image, “enlarged by addition,” for the 2021 and 2022 credit expansions. Together they describe a two-sided rewriting: opponents removed the financing, supporters expanded the subsidies, and the statute that remained at the end of 2022 was thinner in its revenue base and more generous in its benefits than the law enacted in 2010.

Q: If the mandate penalty was zeroed, why did the Supreme Court not decide the mandate was unconstitutional?

Because the Court never reached the constitutional question. In California v. Texas, decided June 17, 2021, the challengers argued that once the payment was zeroed, the coverage requirement could no longer be justified as a tax and was therefore unconstitutional, and that the requirement could not be severed from the rest of the law. The Court did not rule on either argument. Justice Breyer’s majority opinion held that the challengers lacked standing: with no payment owed, they could show no enforcement injury, and without a concrete injury federal courts cannot hear the case. Standing is a threshold question, and failing it ends the lawsuit before the merits are considered. Two justices dissented, but the majority’s logic was procedural rather than substantive. The result is a peculiar entry in constitutional law: the most litigated provision of the statute survived not because the Court upheld it, but because the Court held that no one before it had the right to ask.

Q: Which Affordable Care Act taxes were delayed for years before being repealed?

All three of the repealed levies spent time in limbo before Congress removed them. The Cadillac tax on high-cost employer coverage was postponed twice, first from 2018 to 2020 by the Consolidated Appropriations Act, 2016, then to 2022 by a January 2018 continuing resolution, and never took effect before its December 2019 repeal. The medical device excise tax operated from 2013 through 2015, was suspended for 2016 and 2017, suspended again for 2018 and 2019, and was repealed for sales after December 31, 2019. The annual insurer fee was collected for 2014 through 2016, suspended for 2017, collected for 2018, suspended for 2019, and collected a final time for 2020 before repeal took hold for 2021. The pattern is worth noting: none of the three was repealed in its original operating form. Each was first softened by delay or suspension, which drained the political urgency around it, and the repeals then formalized a status quo that Congress had already created.